Kymera Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Kymera Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Kymera Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Kymera Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $12M | 297k | 40.20 |
| 2023-12-31 | $7.6M | 301k | 25.46 |
| 2023-09-30 | $2.3M | 163k | 13.90 |
| 2023-06-30 | $5.5M | 241k | 22.99 |
| 2023-03-31 | $5.5M | 185k | 29.63 |
| 2022-12-31 | $5.1M | 203k | 24.96 |
| 2022-09-30 | $1.1M | 50k | 22.04 |
| 2022-06-30 | $2.2M | 112k | 19.69 |
| 2022-03-31 | $5.5M | 136k | 40.61 |
| 2021-12-31 | $4.4M | 69k | 63.46 |
| 2021-09-30 | $778k | 13k | 58.77 |
| 2021-06-30 | $1.3M | 27k | 48.49 |
| 2021-03-31 | $989k | 25k | 38.86 |
| 2020-12-31 | $225k | 3.6k | 62.25 |
| 2020-09-30 | $7.0k | 231 | 30.30 |